findmyKOL
Clinical trialNCT05805605RecruitingPhase 2Interventional

Allo HSCT Using RIC and PTCy for Hematological Diseases

SponsorMasonic Cancer Center, University of MinnesotaEnrollment56Acute Lymphocytic LeukemiaAcute Myelogenous LeukemiaBiphenotypic Acute LeukemiaBurkitt LymphomaChronic Myelogenous LeukemiaFollicular Lymphoma+12 more conditions
View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

This is a Phase II study following subjects proceeding with our Institutional non-myeloablative cyclophosphamide/ fludarabine/total body irradiation (TBI) preparative regimen followed by a related, unrelated, or partially matched family donor stem cell infusion using post-transplant cyclophosphamide (PTCy), sirolimus and MMF GVHD prophylaxis.
clinicaltrials.gov ↗

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

1 registered facility, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States
  • Masonic Cancer Center at University of Minnesota

    Minneapolis, Minnesota, United States

    Recruiting

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.

Allopurinol →Bone Marrow Cell TransplantCyclophosphamide →Fludarabine →Mycophenolate mofetil →Peripheral Blood Stem Cell TransplantSirolimus →
Linked drugs open the directory filtered to KOLs working with them.clinicaltrials.gov ↗

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
1 May 2023
Primary completion
22 Oct 2027
Completion
22 Oct 2028
Last update posted
6 Jul 2026
Registered enrollment
56
Registry id
NCT05805605
clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.